McAdam M, Brar R, Young S Initiation of injectable opioid agonist treatment in hospital: a case report Drug Alcohol Rev, 2020. PubMed
Randhawa P, Brar R, Nolan S Buprenorphine-naloxone "microdosing": an alternative induction approach for the treatment of opioid use disorder in the wake of North America's increasingly potent illicit drug market CMAJ, 2020. PubMed
van Draanen J Unique roles of childhood poverty and adversity in the development of lifetime co-occurring disorder SSM Popul Health, 2020. PubMed
Fleming T, Barker A, Ivsins A, Vakharia S, McNeil R Stimulant safe supply: a potential opportunity to respond to the overdose epidemic Harm Reduct J, 2020. PubMed
McCrae K, Tobias S, Grant C, Lysyshyn M, Laing R, Wood E, Ti L Assessing the limit of detection of Fourier-transform infrared spectroscopy and immunoassay strips for fentanyl in a real-world setting Drug Alcohol Rev, 2020. PubMed
Prangnell A, Imtiaz S, Karamouzian M, Hayashi K Childhood abuse as a risk factor for injection drug use: a systematic review of observational studies Drug Alcohol Rev, 2020. PubMed
Bardwell G, Strike C, Mitra S, Scheim A, Barnaby L, Altenberg J, Kerr T “That’s a double-edged sword”: Exploring the integration of supervised consumption services within community health centres in Toronto, Canada Health Place, 2020. PubMed
Adams J, Marshall B, Mohd Salleh NA, Barrios R, Nolan S, Milloy MJ Receipt of opioid agonist treatment halves the risk of HIV-1 RNA viral load rebound through improved ART adherence for HIV-infected women who use illicit drugs Drug Alcohol Depend, 2020. PubMed
Pilarinos A, Barker B, Nosova E, Milloy MJ, Hayashi K, Wood E, Kerr T, DeBeck K Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada Addiction, 2020. PubMed
Socías ME, Nosova E, Lake S, Hayashi K, Kerr T, Milloy MJ A call for experimental research on the risks and benefits of cannabis in the context of treatment for opioid use disorder CMAJ Open, 2019. Link
